Fortress Biotech Inc (FBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 152,483 | 178,266 | 208,351 | 248,771 | 287,511 |
| Receivables | 28,252 | 28,346 | 28,686 | 29,047 | 31,814 |
| Inventories | 13,278 | 14,159 | 15,230 | 16,053 | 16,137 |
| TOTAL | $202,381 | $230,432 | $257,994 | $298,991 | $341,186 |
| Non-Current Assets | |||||
| PPE Net | 12,194 | 13,020 | 13,773 | 14,021 | 14,430 |
| Intangibles | 26,128 | 27,197 | 28,424 | 29,440 | 30,457 |
| Other Non-Current Assets | 22,848 | 23,652 | 23,370 | 21,503 | 21,857 |
| TOTAL | $61,170 | $63,869 | $65,567 | $64,964 | $66,744 |
| Total Assets | $263,551 | $294,301 | $323,561 | $363,955 | $407,930 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 3,000 | 2,948 | 0 | 0 | N/A |
| Accounts payable and accrued liabilities | 105,419 | 97,446 | 93,817 | 93,540 | 91,268 |
| Other current liabilities | 14,982 | 16,917 | N/A | N/A | N/A |
| TOTAL | $129,473 | $127,715 | $106,303 | $104,921 | $103,140 |
| Non-Current Liabilities | |||||
| Long Term Debt | 91,446 | 93,142 | 92,539 | 89,419 | 88,772 |
| Deferred Revenues | 547 | N/A | 1,093 | 1,457 | 2,034 |
| Other Non-Current Liabilities | 56,434 | 53,916 | 53,916 | 54,487 | 56,158 |
| TOTAL | $114,272 | $116,561 | $115,906 | $111,332 | $111,212 |
| Total Liabilities | $243,745 | $244,276 | $222,209 | $216,253 | $214,352 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,960 | 8,655 | 7,245 | 7,186 | 7,164 |
| Common Shares | 130 | 7 | 108 | 108 | 106 |
| Retained earnings | -655,770 | -634,233 | -607,090 | -584,579 | -563,223 |
| Other shareholders' equity | -17,990 | 8,304 | 39,681 | 70,479 | 95,719 |
| TOTAL | $19,806 | $50,025 | $101,352 | $147,702 | $193,578 |
| Total Liabilities And Equity | $263,551 | $294,301 | $323,561 | $363,955 | $407,930 |